Showing results (151-160 of 320) with videos related to

Sort By:
Pageof 32
The Journal of Pain|June 17, 2026
Psychometric Evaluation and Discriminative Validity of the Short-Form Brief Pain Inventory Across Nociceptive, Neuropathic, and Nociplastic Pain MechanismsJeremy P Steen, Kishore S Jaiswal, Joana Dilipkumar, et al.
The Lancet. Rheumatology|March 5, 2026
Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumabAthimalaipet V Ramanan, Nicolino Ruperto, Ivan Foeldvari, et al.
Annals of the Rheumatic Diseases|June 24, 2020
Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trialSeza Ozen, Eldad Ben-Cherit, Ivan Foeldvari, et al.
Rheumatology (Oxford, England)|October 12, 2022
Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survivalFranz Thiele, Ariane Klein, Jens Klotsche, et al.
RMD Open|October 25, 2022
Medication burden in young adults with juvenile idiopathic arthritis: data from a multicentre observational studyLaura J Montag, Gerd Horneff, Paula Hoff, et al.
Arthritis Research & Therapy|January 29, 2016
Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort studyChristopher R Pasarikovski, John T Granton, Adrienne M Roos, et al.
Arthritis Care & Research|May 26, 2017
Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic DataNicolai Leuchten, Annika Hoyer, Ralph Brinks, et al.
ACR Open Rheumatology|September 30, 2024
Evaluation of Progression From Preclinical to Systemic Autoimmune Rheumatic Disease: Novel Use of the European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria as an Outcome MeasureSindhu R Johnson, Hana Alahmari, Dennisse Bonilla, et al.
Arthritis Care & Research|July 26, 2018
Time of Disease-Modifying Antirheumatic Drug Start in Juvenile Idiopathic Arthritis and the Likelihood of a Drug-Free Remission in Young AdulthoodKirsten Minden, Gerd Horneff, Martina Niewerth, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2025
Differences in IgG Sialylation Distinguish Asymptomatic from Symptomatic Anti-Nuclear Antibody Positive IndividualsCarolina Muñoz-Grajales, Carmen C Ucciferri, Sindhu R Johnson, et al.
Pageof 32